About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

BostonGene to Participate in the 2025 IASLC World Conference on Lung Cancer

Session to Highlight Advanced Computational Methods for Classifying Small Cell Lung Cancer, Including Biomarker-Defined Subtypes, Multiomic Profiling and AI-Enabled Clinical Trial Design

BostonGene, a leader in AI-powered solutions for drug discovery and development, today announced its participation in the 2025 IASLC World Conference on Lung Cancer (WCLC), taking place September 6–9, 2025, at the Fira de Barcelona Gran Via in Barcelona, Spain. Hosted by the International Association for the Study of Lung Cancer, WCLC is the world’s largest multidisciplinary meeting dedicated to lung cancer and other thoracic malignancies, drawing thousands of clinicians, researchers, industry leaders and patient advocates from more than 100 countries to share cutting-edge science and collaborate on improving outcomes for patients worldwide.

Alexander Bagaev, PhD, Chief Product Officer at BostonGene, will participate in the session, “Personalizing Approaches to SCLC: Translating New Understandings of SCLC Heterogeneity into Biomarker-Driven Small Cell Lung Cancer Therapies, alongside experts from Yale University, MD Anderson Cancer Center and Moffitt Cancer Center. The discussion will address recent advances in small cell lung cancer (SCLC), focusing on biomarker-defined subtypes, multiomic tumor profiling, integration of tissue and liquid biopsy data and the role of AI-based platforms in delivering advanced patient stratification to inform trial design and improve the precision of therapeutic development.

  • Date and time: Saturday, September 6 | 8:15 AM
  • Location: Room 09

BostonGene will highlight its clinically validated assay that identifies transcriptional subtypes of SCLC, leveraging its AI-powered multiomic platform to support biomarker strategy, refine trial cohorts and strengthen therapeutic alignment. Already deployed in clinical settings, the platform is streamlining patient matching, enabling flexible trial designs and helping accelerate evaluation of investigational agents in biomarker-enriched programs.

“The IASLC WCLC provides a unique platform to present how BostonGene is applying multiomic profiling and AI-driven analytics to deliver regulatory-grade patient stratification in SCLC,” said Dr. Bagaev. “By enabling precise identification of biomarker-defined subgroups, we support drug developers in optimizing trial design, accelerating development timelines, and increasing the probability of success for novel therapies targeting this aggressive disease.”

About BostonGene Corporation

BostonGene helps drug developers de-risk and accelerate research and development using a clinically validated AI platform purpose-built for oncology and supported by a CLIA-certified and CAP-accredited clinical laboratory. By integrating advanced molecular and immune profiling with clinical data, we uncover actionable insights that inform trial design, optimize patient selection and improve clinical outcomes. Our diagnostic and treatment recommendation solutions are used in clinical settings to personalize care and guide therapy decisions for patients. For more information, visit www.BostonGene.com.

By enabling precise identification of biomarker-defined subgroups, we support drug developers in optimizing trial design, accelerating development timelines, and increasing the probability of success for novel therapies targeting this aggressive disease.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.